Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

PF-1201: new antitumor antibiotic selective for tumor gene-transformed cell lines

May 12, 2000

Kinase inhibitors under evaluation at major German pharmaceutical laboratory

May 11, 2000

Antitumor agents from American Cyanamid act by inhibiting PTKs

May 11, 2000

HMW endostatins for treatment and diagnosis of tumors disclosed by Haemopep

May 11, 2000

CDD and ICRT to collaborate on anticancer drug development

May 11, 2000

Orphan drug status awarded to arsenic trioxide for multiple myeloma

May 11, 2000

ImmunoGen and Genentech sign TAP license agreement

May 11, 2000

Halitulin: a new cytotoxic alkaloid isolated from sponge at Pharma Mar

May 10, 2000

Phase III study of Protegrin IB-367 Rinse begins

May 10, 2000

AEterna initiates patient recruitment for phase III trial of Neovastat

May 10, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...